NIH-funded research R21 grant

Understanding how APP processing affects Alzheimer’s disease at the single-molecule level

Official title: Single-molecule dynamics of amyloid precursor protein with pooled genetic perturbations

Funded at Broad Institute, INC. · NIH-11441972 · Data updated 2026-11-12

A new NIH grant aims to study how the amyloid precursor protein (APP) behaves in brain cells to influence Alzheimer’s disease, using advanced imaging to track single molecules.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionBroad Institute, INC.
NIH-funded
Lab location1 site (Cambridge, United States)
Project startSeptember 3, 2026
Project endAugust 31, 2029
Funding year2026
Award (this year)$698,718
NIH project number1R21AG104127-01
Project IDNIH-11441972 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals at risk for or diagnosed with Alzheimer’s disease or related dementias, for whom future therapies targeting APP processing may be relevant.

Less likely to help

People without risk factors or a diagnosis of Alzheimer’s disease may not directly benefit from this basic science study.

What this research studies

This project will develop a live-cell imaging platform that looks at how APP encounters enzymes that either promote harmful amyloid formation or protective shedding. It combines single-molecule tracking with a new pooled-genomics screen to identify genetic perturbations that change APP processing. The approach uses two imaging modes to balance broad discovery and deep, long-term observation in neurons. The work could reveal precise molecules and interactions to target in future therapies for Alzheimer’s disease.

Why it matters

Potential benefit: Could lead to new targets or strategies to slow or prevent cognitive decline in people with Alzheimer’s disease by altering APP processing.

How similar studies have gone: Previous single-molecule and live-cell imaging studies have provided proof-of-concept for tracking APP-related processes, with growing evidence that detailed molecular insights can guide therapies.

Where this research is happening

  • Broad Institute, INC.
    Cambridge, United States
    Active

Researchers

  • Principal investigator: Peng, Chunte — Broad Institute, INC.
  • Study coordinator: Peng, Chunte

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.